Expression of C-erbB-2 and nm23 proteins in breast cancer and their clinical signifi cance

Hai-tao YIN,Li-feng WANG,Xiao-ping QIAN,Li-xia YU,Bao-rui LIU
DOI: https://doi.org/10.3969/j.issn.1672-4992.2009.02.023
2009-01-01
Journal of Modern Oncology
Abstract:Objective:To investigate the correlation between the expression of c-erbB-2,nm23 proteins and prognosis in breast cancer.Methods: Expression of c-erbB-2 and nm23 proteins in 70 breast cancers were determined by immunohistochemistry.Results: The positive expression rate of c-erbB-2 was 45.7% and had no obvious correlation with the patient age and tumor size(P>0.05),but positive to clinical phase and axillary lymph nodes metastasis(P<0.05).c-erbB-2 positive rate was higher in well-differentiated patients than that in moderately differentiated or poorly differentiated patients(P<0.05).The positive expression rate of nm23 was 68.6% and had no obvious correlation with the patient age and tumor size(P>0.05),but negative to clinical phase,histology grade and axillary lymph nodes metastasis(P<0.05).c-erbB-2 and nm23 expression had obvious negative correlation between them(P<0.05).Conclusion: Combined detection of the expression of c-erbB-2 and nm23 in breast cancer tissue will be more benefit to evaluate the prognosis of the breast cancer patients.
What problem does this paper attempt to address?